Identifying cancer sub-types from genomic scale data sets using confidence based integration (CBI)

Precision medicine is a method involving refined diagnosis of patients and searching for causes that are unseen in their patient cohorts who otherwise have largely similar health conditions. As the technology evolved to extract features from a wide variety of sources including genetics, a large quantum of data is available to the researchers for conducting micro studies in the field of disease and cures. In cancer research, integrative methods using genomic data sets has become a major area of interest. The petabytes of data that is available at The Cancer Genome Atlas (TCGA), a program jointly under NCI and National Human Genome Research Institute, has made possible more nuanced research in cancer genomics. Our method, Confidence Based Integration (CBI) is an integration method to extract similar as well as complementing information from the genomic data sets. This information will provide insight into the status of patients and their prospects. We used the expression data sets of gene, miRNA and DNA methylation in our fusion experiments on five different cancer types. These data sets, after fusion, are clustered using 'Spectral Clustering' algorithm, which derives clusters that form the disease sub types. Survival properties of each sub type demonstrates the reasons to consider the samples inside them highly similar. The performance of CBI, we report, is better, in terms of P-value in log-rank test, than other methods like similarity network fusion or SNF in forming clusters of significance. Individual features clustered extremely poor compared to CBI in most of the experiments.